New scan could spot hidden prostate cancer spread
NCT ID NCT03173924
First seen Nov 01, 2025 · Last updated Jun 15, 2026 · Updated 32 times
Summary
This study compares two types of PET scans to see which better finds prostate cancer that has spread. About 96 adults with metastatic prostate cancer will receive an experimental radiotracer (18F-DCFPyL) and a standard one (18F-NaF) on different days, then have whole-body scans. The goal is to see if the new tracer identifies more cancer sites, which could improve diagnosis and treatment planning.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.